Business Description
Biovica International AB
ISIN : SE0008613731
Share Class Description:
OSTO:BIOVIC B: Class BCompare
Compare
Traded in other countries / regions
BIOVIC B.Sweden9II.Germany IPO Date
2017-03-29Description
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.81 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.74 | |||||
| Beneish M-Score | -1.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13 | |||||
| 3-Year EBITDA Growth Rate | -41.6 | |||||
| 3-Year EPS without NRI Growth Rate | -35.9 | |||||
| 3-Year FCF Growth Rate | -29.6 | |||||
| 3-Year Book Growth Rate | -2.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.67 | |||||
| 9-Day RSI | 31.09 | |||||
| 14-Day RSI | 32.21 | |||||
| 6-1 Month Momentum % | -6.3 | |||||
| 12-1 Month Momentum % | -64.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.27 | |||||
| Quick Ratio | 7.1 | |||||
| Cash Ratio | 6.77 | |||||
| Days Sales Outstanding | 71.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.3 | |||||
| Shareholder Yield % | 2.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 113.43 | |||||
| Operating Margin % | -1929 | |||||
| Net Margin % | -1938.68 | |||||
| FCF Margin % | -1883.31 | |||||
| ROE % | -96.3 | |||||
| ROA % | -79.48 | |||||
| ROIC % | -195.74 | |||||
| ROC (Joel Greenblatt) % | -1145.1 | |||||
| ROCE % | -87.77 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.05 | |||||
| PB Ratio | 0.99 | |||||
| Price-to-Tangible-Book | 1.33 | |||||
| EV-to-EBIT | -0.34 | |||||
| EV-to-Forward-EBIT | -0.91 | |||||
| EV-to-EBITDA | -0.37 | |||||
| EV-to-Forward-EBITDA | -1.18 | |||||
| EV-to-Revenue | 6.3 | |||||
| EV-to-Forward-Revenue | 1 | |||||
| EV-to-FCF | -0.32 | |||||
| Price-to-Net-Current-Asset-Value | 1.51 | |||||
| Price-to-Net-Cash | 1.65 | |||||
| Earnings Yield (Greenblatt) % | -299.36 | |||||
| FCF Yield % | -87.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biovica International AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 6.344 | ||
| EPS (TTM) (kr) | -2.574 | ||
| Beta | 0 | ||
| Volatility % | 82.86 | ||
| 14-Day RSI | 32.21 | ||
| 14-Day ATR (kr) | 0.245686 | ||
| 20-Day SMA (kr) | 1.90145 | ||
| 12-1 Month Momentum % | -64.74 | ||
| 52-Week Range (kr) | 1.5 - 10.36 | ||
| Shares Outstanding (Mil) | 84.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biovica International AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biovica International AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biovica International AB Frequently Asked Questions
What is Biovica International AB(OSTO:BIOVIC B)'s stock price today?
The current price of OSTO:BIOVIC B is kr1.63. The 52 week high of OSTO:BIOVIC B is kr10.36 and 52 week low is kr1.50.
When is next earnings date of Biovica International AB(OSTO:BIOVIC B)?
The next earnings date of Biovica International AB(OSTO:BIOVIC B) is 2024-06-18.
Does Biovica International AB(OSTO:BIOVIC B) pay dividends? If so, how much?
Biovica International AB(OSTO:BIOVIC B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers